Skip to main content
Log in

Challenges in Treating Pediatric Asthma in Developing Countries

  • Leading Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Asthma is the most common chronic disease in children in many low- and middle-income countries. In these settings, the burden of childhood asthma is increasing and is associated with severe disease. There are a number of challenges to providing optimal management of childhood asthma in such settings. These include under-diagnosis of childhood asthma, access to care, ability of healthcare workers to manage asthma, availability and affordability of inhaled therapy, environmental control of potential triggers, education of healthcare providers and of the public, and cultural or language issues.

International and national guidelines for childhood asthma have been produced, but implementation remains a real challenge. Access to and affordability of essential inhaled asthma drugs, especially low-dose inhaled corticosteroids and short-acting bronchodilators, are major challenges to effective asthma control in many countries. A low-cost spacer made from a plastic bottle is effective for use with a metered-dose inhaler, but use must be included in asthma educational initiatives. Educational programs for healthcare personnel and for the public that are culturally and language appropriate are needed for effective implementation of asthma guidelines. Socioeconomic and structural barriers to care within health services remain obstacles to achieving optimal treatment of asthma for many children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Asher MI, Montefort S, Björksten B, et al., and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733–7

    Article  PubMed  Google Scholar 

  2. Pearce N, Ait-Khaled N, Beasley R, et al., and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 757–65

    Article  Google Scholar 

  3. Ait-Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007 Mar; 62 (3): 247–58

    Article  PubMed  CAS  Google Scholar 

  4. Lai CK, Beasley R, Crane J, et al., International Study of Asthma and Allergies in Childhood Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476–83

    Article  PubMed  CAS  Google Scholar 

  5. Crane J, Mallol J, Beasley R, et al. Agreement between written and video questions for comparing asthma symptoms in ISAAC. International Study of Asthma and Allergies in Childhood Phase I Study Group. Eur Respir J 2003 Mar; 21 (3): 455–61

    Article  PubMed  CAS  Google Scholar 

  6. Masoli M, Fabian D, Holt S, et al., Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59 (5): 469–78

    Article  PubMed  Google Scholar 

  7. World Health Organisation. WHO indicator and measurement registry [online]. Available from URL: http://apps.who.int [Accessed 2012 Aug 1]

  8. Lalloo UG, Walters RD, Adachi M, et al. Asthma programs in diverse regions of the world: challenges, successes and lessons learnt. Int J Tuber Lung Dis 2011; 15 (12): 1574–87

    Article  CAS  Google Scholar 

  9. Tan WC. Asthma management in the developing world: achievements and challenges. Expert Rev Respir Med 2008; 2 (3): 323–8

    Article  PubMed  Google Scholar 

  10. Pedersen SE, Hurd SS, Lemanske Jr RF, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011; 46: 1–17

    Article  PubMed  Google Scholar 

  11. Castro-Rodriguez JA, Holberg CJ, Wright AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162 (4 Pt 1): 1403–6

    Article  PubMed  CAS  Google Scholar 

  12. Weinmayr G, Weiland SK, Björksten B, et al. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007; 176 (6): 565–74

    Article  PubMed  Google Scholar 

  13. Padhi BK, Padhy PK. Domestic fuels, indoor air pollution, and children’s health. Ann N Y Acad Sci 2008; 1140: 209–17

    Article  PubMed  CAS  Google Scholar 

  14. Stern DA, Morgan WJ, Halonen M, et al. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008; 372 (9643): 1058–64

    Article  PubMed  Google Scholar 

  15. Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology 2003; 8 (3): 266–85

    Article  PubMed  Google Scholar 

  16. Dezateux C, Stocks J, Wade AM, et al. Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking. Thorax 2001; 56 (9): 680–6

    Article  PubMed  CAS  Google Scholar 

  17. Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 2008; 177 (6): 567–73

    Article  PubMed  CAS  Google Scholar 

  18. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2011 [online]. Available from URL: http://www.ginasthma.org [Accessed 2012 Aug 23]

  19. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32 (4): 1096–110

    Article  PubMed  CAS  Google Scholar 

  20. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006 Apr 19; (2): CD000052

    Google Scholar 

  21. Zar HJ, Weinberg EG. Spacer devices for the developing world. ACI International 2002; 14 (1): 13–6

    Google Scholar 

  22. WHO model list of essential medicines, 15th list, March 2007. Geneva: World Health Organization, 2007 [online]. Available from URL: http://www.who.int/medicines/publications/essentialmedicines/en/index.html [Accessed 2012 Aug 24]

  23. Zar HJ, Brown G, Donson H, et al. Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial. Lancet 1999; 354: 979–82

    Article  PubMed  CAS  Google Scholar 

  24. Rodriguez C, Sossa M, Lozano JM. Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children. Cochrane Database Syst Rev 2008; (2): CD005536

  25. Zar H, Streun S, Levin M, et al. Randomised controlled trial of the efficacy of a metered dose inhaler with bottle spacer for bronchodilator therapy in acute lower airway obstruction. Arch Dis Child 2007; 92: 142–6

    Article  PubMed  CAS  Google Scholar 

  26. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354 (19): 1985–97

    Article  PubMed  CAS  Google Scholar 

  27. Lemanske Jr RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362 (11): 975–85

    Article  PubMed  CAS  Google Scholar 

  28. Ellis EF. Theophylline toxicity. J Allergy Clin Immunol 1985; 76 (2 Pt 2): 297–301

    Article  PubMed  CAS  Google Scholar 

  29. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007; 85 (4): 279–88

    Article  PubMed  Google Scholar 

  30. Kotwani A. Availability, price and affordability of asthma medicines in five Indian states. Int J Tuberc Lung Dis 2009; 13 (5): 574–9

    PubMed  CAS  Google Scholar 

  31. Robertson J, Forte G, Trapsida JM, et al. What essential medicines for children are on the shelf? Bull World Health Organ 2009; 87 (3): 231–7

    Article  PubMed  Google Scholar 

  32. Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci 2011; 100 (11): 4571–9

    Article  PubMed  CAS  Google Scholar 

  33. USAID. Promoting the quality of medicines in developing countries [online]. Available from URL: http://www.usp.org/worldwide/ [Accessed 2011 Oct 25]

  34. Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health 2007; 7: 82

    Article  PubMed  Google Scholar 

  35. Ponte E, Franco RA, Souza-Machado A, et al. Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil. J Bras Pneumol 2007; 33 (1): 15–9

    Article  PubMed  Google Scholar 

  36. Neffen H, Baena-Cagnani C, Passalacqua G, et al. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990–1999). Respir Med 2006; 100: 1431–5

    Article  PubMed  Google Scholar 

  37. Kupczyk M, Haahtela T, Cruz AA, et al. Reduction of asthma burden is possible through National Asthma Plans. Allergy 2010; 65 (4): 415–9

    Article  PubMed  CAS  Google Scholar 

  38. Flores G, Snowden-Bridon C, Torres S, et al. Urban minority children with asthma: substantial morbidity, compromised quality and access to specialists, and the importance of poverty and specialty care. J Asthma 2009; 46 (4): 392–8

    Article  PubMed  Google Scholar 

  39. Kim H, Kieckhefer GM, Greek AA, et al. Health care utilization by children with asthma. Prev Chronic Dis 2009; 6 (1): A12

    PubMed  Google Scholar 

  40. Zar HJ, Stickells D, Toerien A, et al. Changes in fatal and near fatal asthma in an urban area of South Africa from 1980–1997. Eur Respir J 2001; 18: 33–7

    Article  PubMed  CAS  Google Scholar 

  41. Cane RS, McKenzie SA. Parents’ interpretations of children’s respiratory symptoms on video. Arch Dis Child 2001; 84: 31–4

    Article  PubMed  CAS  Google Scholar 

  42. Michel G, Silverman M, Strippoli MP, et al. Parental understanding of wheeze and its impact on asthma prevalence estimates. Eur Respir J 2006; 28 (6): 1124–30

    Article  PubMed  CAS  Google Scholar 

  43. Greenfield RO, Lee AC, Tang R, et al. Screening for asthma in Cantonese-speaking immigrant children. BMC Public Health 2005; 5: 48

    Article  PubMed  Google Scholar 

  44. Saglani S, McKenzie SA, Bush A, et al. A video questionnaire identifies upper airway abnormalities in preschool children with reported wheeze. Arch Dis Child 2005; 90 (9): 961–4

    Article  PubMed  CAS  Google Scholar 

  45. Levin ME. Different use of medical terminology and culture-specific models of disease affecting communication between Xhosa-speaking patients and English-speaking doctors at a South African paediatric teaching hospital. S Afr Med J 2006; 96 (10): 1080–4

    PubMed  CAS  Google Scholar 

  46. Thompson L, Diaz J, Jenny A, et al. Nxwisen, ntzarrin or ntzo’lin? Mapping children’s respiratory symptoms among indigenous populations in Guatemala. Soc Sci Med 2007; 65 (7): 1337–50

    Article  PubMed  Google Scholar 

  47. Phankingthongkum S, Daengsuwan T, Visitsunthorn N, et al. How do Thai children and adolescents describe asthma symptoms? Pediatr Allergy Immunol 2002; 13 (2): 119–24

    Article  PubMed  Google Scholar 

  48. Lai CK, Chan JK, Chan A, et al. Comparison of the ISAAC video questionnaire (AVQ3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy 1997; 27 (5): 540–5

    Article  PubMed  CAS  Google Scholar 

  49. Levin ME. Use of asthma terminology by Xhosa-speaking patients in South Africa: how it affects asthma-control questionnaires and questionnaire-based epidemiological studies. Curr Allergy Clin Immunol 2007; 20 (2): 74–8

    Google Scholar 

  50. Enarson DA, Ait-Khaled N. Cultural barriers to asthma management. Pediatr Pulmonol 1999; 28 (4): 297–300

    Article  PubMed  CAS  Google Scholar 

  51. Kleinman A, Eisenberg L, Good B. Culture illness and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978; 88: 251–8

    Article  PubMed  CAS  Google Scholar 

  52. Pachter LM, Weller SC, Baer RD, et al. Variation in asthma beliefs and practices among mainland Puerto Ricans, Mexican-Americans, Mexicans, and Guatemalans. J Asthma 2002; 39 (2): 119–34

    Article  PubMed  Google Scholar 

  53. Deng Z. TCM diet therapy for bronchial asthma. J Tradit Chin Med 2009; 29 (3): 209–10

    Article  PubMed  Google Scholar 

  54. Laster N, Holsey CN, Shendell DG, et al. Barriers to asthma management among urban families: caregiver and child perspectives. J Asthma 2009; 46 (7): 731–9

    Article  PubMed  Google Scholar 

  55. Griffiths C, Kaur G, Gantley M, et al. Influences on hospital admission for asthma in south Asian and white adults: qualitative interview study. BMJ 2001; 323 (7319): 962–6

    Article  PubMed  CAS  Google Scholar 

  56. Boyd M, Lasserson TJ, McKean MC, et al. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev 2009; (2): CD001290

    PubMed  Google Scholar 

  57. Zemek RL, Bhogal SK, Ducharme FM. Systematic review of randomized controlled trials examining written action plans in children: what is the plan? Arch Pediatr Adolesc Med 2008; 162 (2): 157–63

    Article  PubMed  Google Scholar 

  58. Espinoza-Palma T, Zamorano A, Arancibia F, et al. Effectiveness of asthma education with and without a self-management plan in hospitalized children. J Asthma 2009; 46 (9): 906–10

    Article  PubMed  Google Scholar 

  59. Bailey EJ, Cates CJ, Kruske SG, et al. Culture-specific programs for children and adults from minority groups who have asthma. Cochrane Database Syst Rev 2009; (2): CD006580

  60. Chang AB, Shannon C, O’Neil MC, et al. Asthma management in indigenous children of a remote community using an indigenous health model. J Paediatr Child Health 2000; 36 (3): 249–51

    Article  PubMed  CAS  Google Scholar 

  61. Ait-Khaled N, Enarson DA, Bissell K, et al. Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries. Allergy 2007; 62 (3): 230–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to prepare this manuscript. Heather Zar has received educational support from GlaxoSmithKline for travel to international respiratory meetings. Michael Levin has received funding from ThermoFisher and Schering Plough to attend conferences, is on the advisory boards of Cipla and Pharmadynamics, has received research support from ThermoFisher and GlaxoSmithKline and has received remuneration as a speaker from Cipla, Sanofi-Aventis and Schering Plough.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heather J. Zar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zar, H.J., Levin, M.E. Challenges in Treating Pediatric Asthma in Developing Countries. Pediatr Drugs 14, 353–359 (2012). https://doi.org/10.1007/BF03262416

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262416

Keywords

Navigation